bosentan anhydrous has been researched along with Myocardial Infarction in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (33.33) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belaidi, E; Godin-Ribuot, D; Joyeux-Faure, M; Launois, SH; Levy, P; Ribuot, C | 1 |
| Bengtsson, M; Kalani, M; Papadogeorgos, NO | 1 |
| Chen, CC; Hsu, YJ; Lee, TM; Lien, HY; Lin, CC; Shih, CM | 1 |
| Dupuis, J; Jiang, BH; Shi, Y; Tardif, JC | 1 |
| Bengel, FM; Dannals, RF; Fukushima, K; Higuchi, T; Isoda, T; Javadi, MS; Mathews, WB; Rischpler, C; Szabo, Z; Xia, J | 1 |
| Amit, S; Kumar, OS; Mukesh, N; Rajan, M; Singh, AD | 1 |
| Agelaki, MG; Baltogiannis, GG; Fotiadis, DI; Fotopoulos, A; Kolettis, TM; Kyriakides, ZS; Tsalikakis, DG; Tzallas, AT | 1 |
| Chang, NC; Lee, TM; Lin, MS | 1 |
| Chang, NC; Chen, CC; Lee, TM; Lin, MS | 1 |
| Bugge, E; Ytrehus, K | 1 |
| Comoy, E; Compagnon, P; Derumeaux, G; Henry, JP; Hogie, M; Lallemand, F; Letac, B; Macé, B; Mulder, P; Richard, V; Thuillez, C | 1 |
| Ertl, G; Fraccarollo, D; Galuppo, P; Gaudron, P; Hu, K | 1 |
| Akima, T; Hanada, K; Kawai, N; Nishikibe, M; Ohta, H; Suzuki, J | 1 |
| Attramadal, H; Bjønerheim, R; Grogaard, HK; Kongshaug, H; Oie, E; Smiseth, OA | 1 |
| Colucci, WS; Sam, F | 1 |
| Bauersachs, J; Ertl, G; Fraccarollo, D; Galuppo, P; Widder, J | 1 |
| Hannan, RD; Krum, H; Lim, S; See, F; Tzanidis, A; Ugoni, AM | 1 |
| Clozel, JP; Clozel, M; Ding, SS; Hess, P; Qiu, C; Xi, JF | 1 |
1 review(s) available for bosentan anhydrous and Myocardial Infarction
| Article | Year |
|---|---|
Endothelin-1 in heart failure: does it play a role?
Topics: Animals; Bosentan; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Heart Failure; Hemodynamics; Humans; Mice; Myocardial Infarction; Myocardium; Peptides, Cyclic; Rats; Receptors, Endothelin; Stroke Volume; Sulfonamides; Time Factors | 1998 |
1 trial(s) available for bosentan anhydrous and Myocardial Infarction
| Article | Year |
|---|---|
Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes.
Topics: Aged; Angioplasty, Balloon, Coronary; Bosentan; Coronary Artery Disease; Coronary Circulation; Diabetes Mellitus, Type 2; Endothelin A Receptor Antagonists; Female; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Peptides, Cyclic; Receptor, Endothelin A; Stents; Sulfonamides; Treatment Outcome | 2009 |
16 other study(ies) available for bosentan anhydrous and Myocardial Infarction
| Article | Year |
|---|---|
Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Disease Models, Animal; Endothelin-1; Genetic Predisposition to Disease; Heart; Hypertension; Hypoxia; Hypoxia-Inducible Factor 1; Male; Myocardial Infarction; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sleep Apnea, Obstructive; Sulfonamides | 2009 |
Effect of pravastatin on ventricular arrhythmias in infarcted rats: role of connexin43.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blotting, Western; Bosentan; Cardiac Pacing, Artificial; Connexin 43; Disease Models, Animal; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelin-1; Fluorescent Antibody Technique; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Maleimides; Mevalonic Acid; Myocardial Infarction; Myocardium; Pravastatin; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Wistar; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Time Factors; Ultrasonography | 2010 |
Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure.
Topics: Animals; Antihypertensive Agents; Bosentan; Disease Models, Animal; Echocardiography; Endothelin Receptor Antagonists; Heart Failure; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Lung; Myocardial Infarction; Prognosis; Rats; Sulfonamides | 2011 |
Targeting of endothelin receptors in the healthy and infarcted rat heart using the PET tracer 18F-FBzBMS.
Topics: Animals; Benzamides; Bosentan; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Heart; Male; Myocardial Infarction; Myocardium; Nuclear Medicine; Perfusion; Positron-Emission Tomography; Rats; Rats, Wistar; Receptors, Endothelin; Sulfonamides; Thallium Radioisotopes; Time Factors | 2013 |
Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats.
Topics: Animals; Blood Pressure; Bosentan; Cardiotonic Agents; Creatine Kinase; Diastole; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Heart Rate; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Sulfonamides; Survival Analysis; Systole; Time Factors | 2006 |
Effects of dual endothelin receptor blockade on sympathetic activation and arrhythmogenesis during acute myocardial infarction in rats.
Topics: Action Potentials; Animals; Antihypertensive Agents; Bosentan; Electrocardiography; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Epinephrine; Myocardial Infarction; Norepinephrine; Random Allocation; Rats; Rats, Wistar; Sulfonamides; Sympathetic Nervous System; Tachycardia, Ventricular; Telemetry; Ventricular Fibrillation | 2008 |
Physiological concentration of 17beta-estradiol on sympathetic reinnervation in ovariectomized infarcted rats.
Topics: Animals; Bosentan; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Estradiol; Estrogen Antagonists; Estrogens; Female; GAP-43 Protein; Myocardial Infarction; Nerve Growth Factor; Nerve Regeneration; Norepinephrine; Ovariectomy; Rats; Rats, Wistar; Sulfonamides; Sympathetic Nervous System; Tamoxifen; Tyrosine 3-Monooxygenase | 2008 |
Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats.
Topics: Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atrasentan; Blotting, Western; Bosentan; Cardiac Pacing, Artificial; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; GAP-43 Protein; Hemodynamics; Hydralazine; Immunohistochemistry; Male; Methoxyhydroxyphenylglycol; Myocardial Infarction; Myocardium; Nerve Growth Factor; Neurofilament Proteins; Norepinephrine; Polymerase Chain Reaction; Pyrrolidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Sulfonamides; Sympathetic Nervous System; Time Factors; Tyrosine 3-Monooxygenase; Up-Regulation | 2008 |
Endothelin-1 can reduce infarct size through protein kinase C and KATP channels in the isolated rat heart.
Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Benzophenanthridines; Bosentan; Coronary Circulation; Decanoic Acids; Endothelin Receptor Antagonists; Endothelins; Hydroxy Acids; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardium; Peptides, Cyclic; Perfusion; Phenanthridines; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Rats; Rats, Wistar; Sulfonamides | 1996 |
Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Cardiac Volume; Chronic Disease; Collagen; Consciousness; Coronary Vessels; Cyclic GMP; Echocardiography; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Heart Failure; Heart Ventricles; Male; Myocardial Infarction; Myocardium; Norepinephrine; Pressure; Protein Precursors; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Survival Analysis; Ventricular Function, Left | 1997 |
Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling.
Topics: Animals; Antihypertensive Agents; Bosentan; Dose-Response Relationship, Drug; Endothelin-1; Female; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Myocardial Infarction; Rats; Rats, Wistar; Receptors, Endothelin; Sulfonamides; Time Factors | 1997 |
Hemodynamic effect of endothelin antagonists in dogs with myocardial infarction.
Topics: Animals; Antihypertensive Agents; Bosentan; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hemodynamics; Male; Myocardial Infarction; Peptides, Cyclic; Receptor, Endothelin A; Receptor, Endothelin B; Renin-Angiotensin System; Structure-Activity Relationship; Sulfonamides | 1998 |
ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats.
Topics: Angiotensinogen; Animals; Bosentan; Coronary Vessels; Endothelin Receptor Antagonists; Gene Expression; Heart Failure; Hypertrophy, Left Ventricular; Ligation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; RNA, Messenger; Sulfonamides; Ventricular Function, Left | 1998 |
Endothelin-receptor blockade improves endothelial vasomotor dysfunction in heart failure.
Topics: Acetylcholine; Analysis of Variance; Animals; Aorta; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Heart Failure; In Vitro Techniques; Male; Myocardial Infarction; Nitroprusside; Oxygen; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Renin; Sulfonamides; Superoxide Dismutase; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Combined angiotensin and endothelin receptor blockade attenuates adverse cardiac remodeling post-myocardial infarction in the rat: possible role of transforming growth factor beta(1).
Topics: Angiotensin Receptor Antagonists; Animals; Blotting, Northern; Bosentan; Collagen; Endothelin Receptor Antagonists; Female; Fibroblasts; Hemodynamics; Hypertrophy, Left Ventricular; Immunohistochemistry; Macrophages; Monocytes; Myocardial Infarction; Myocardium; Procollagen; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides; Tetrazoles; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Valine; Valsartan; Ventricular Dysfunction, Left | 2001 |
Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure.
Topics: Animals; Antihypertensive Agents; Bosentan; Drug Administration Schedule; Endothelin Receptor Antagonists; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Natriuresis; Rats; Rats, Wistar; Renal Circulation; Sulfonamides; Vasoconstriction | 2002 |